68Ga-DOTATATE Uptake in Pancreatic Metastasis of Renal Cell Carcinoma Mimicking Pancreatic Neuroendocrine Tumor.
Biological Transport
Carcinoma, Renal Cell
/ pathology
Humans
Kidney Neoplasms
/ pathology
Male
Middle Aged
Neuroendocrine Tumors
/ diagnostic imaging
Organometallic Compounds
/ metabolism
Pancreatic Neoplasms
/ diagnostic imaging
Positron Emission Tomography Computed Tomography
Receptors, Somatostatin
/ metabolism
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
pubmed:
16
7
2019
medline:
21
11
2019
entrez:
16
7
2019
Statut:
ppublish
Résumé
A 61-year-old man, with a history of prior clear cell renal cell carcinoma in remission, was referred to Ga-DOTATATE PET/CT for the further evaluation of pancreatic tail mass. Ga-DOTATATE PET/CT showed pathologically intense uptake on the pancreatic mass; subsequent biopsy of the pancreatic mass confirmed the diagnosis of clear cell renal cell carcinoma metastasis. Ga-DOTATATE uptake is not specific for neuroendocrine tumors. In the presence of prior malignancy, it should be kept in mind that malignancies apart from neuroendocrine tumors express somatostatin receptors, and they can show Ga-DOTATATE uptake.
Identifiants
pubmed: 31306201
doi: 10.1097/RLU.0000000000002718
doi:
Substances chimiques
Organometallic Compounds
0
Receptors, Somatostatin
0
gallium Ga 68 dotatate
9L17Y0H71P
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM